LSLS
Lila Sciences
NewScientific superintelligence for drug discovery
AISeries AEst. 202350-200 employeesCambridge
Lila Sciences is building AI systems that can autonomously conduct scientific experiments and accelerate drug discovery. Their platform integrates wet-lab automation with AI reasoning to compress years of pharmaceutical R&D into weeks.
Total Raised$200M
Andreessen Horowitz
Founders
D
Daphne KollerB
Bernardo Sabatini
